Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations.
about
The value of neuraminidase inhibitors for the prevention and treatment of seasonal influenza: a systematic review of systematic reviewsReporting bias in medical research - a narrative reviewThe imperative to share clinical study reports: recommendations from the Tamiflu experienceVaccines and antiviral drugs in pandemic preparednessNeuraminidase inhibitors for preventing and treating influenza in healthy adults and childrenNeuraminidase inhibitors for preventing and treating influenza in healthy adults and children - a review of clinical study reportsNeuraminidase inhibitors for preventing and treating influenza in healthy adultsNeuraminidase inhibitors for preventing and treating influenza in healthy adultsNeuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysisCurrent and future antiviral therapy of severe seasonal and avian influenzaInfluenza and the use of oseltamivir in childrenVirus-induced secondary bacterial infection: a concise reviewViral-bacterial interactions-therapeutic implicationsWhat is the role of respiratory viruses in community-acquired pneumonia?: What is the best therapy for influenza and other viral causes of community-acquired pneumonia?Virus-induced exacerbations in asthma and COPDInfluenza Induced Cardiomyopathy: An Unusual Cause of Hypoxemia.Pathophysiology of viral-induced exacerbations of COPDOseltamivir is adequately absorbed following nasogastric administration to adult patients with severe H5N1 influenzaCompliance to oseltamivir among two populations in Oxfordshire, United Kingdom affected by influenza A(H1N1)pdm09, November 2009--a waste water epidemiology studyThe Tamiflu fiasco and lessons learntPandemic influenza: antiviral preparedness and health care workers.Intervention strategies for an influenza pandemic taking into account secondary bacterial infectionsInfluenza pandemic intervention planning using InfluSim: pharmaceutical and non- pharmaceutical interventions.Cost-effective approaches to influenza prevention and treatment.A Narrative Review of Influenza: A Seasonal and Pandemic Disease.Antiviral therapy of influenza.Cost-benefit of stockpiling drugs for influenza pandemic.Oseltamivir in the management of influenza.Preparing for pandemic influenza: should hospitals stockpile oseltamivir?Economics of neuraminidase inhibitor stock piling for pandemic influenza, SingaporePandemics, avian influenza A (H5N1), and a strategy for pharmacists.Insights into the interaction between influenza virus and pneumococcusEffectiveness of neuraminidase inhibitors in preventing hospitalization during the H1N1 influenza pandemic in British Columbia, Canada.Antiviral management of seasonal and pandemic influenza.Pandemic flu: clinical management of patients with an influenza-like illness during an influenza pandemic. Provisional guidelines from the British Infection Society, British Thoracic Society, and Health Protection Agency in collaboration with the DeEffectiveness of neuraminidase inhibitors for preventing staff absenteeism during pandemic influenzaThe role of oseltamivir in the treatment and prevention of influenza in children.Antivirals and the control of influenza outbreaks.Influenza infection and COPD.Cost-effectiveness of antiviral stockpiling and near-patient testing for potential influenza pandemic.
P2860
Q21090775-DF7BDAC2-6231-42C6-844B-019AD81FA69BQ21203744-572ED594-6BA1-441C-AA89-16B003A172A5Q21563018-84F2CB49-86D1-4434-B6B2-92C06E6E6F31Q22305646-34560748-ABDE-4256-89DE-7C75D8DFA8AFQ24203905-48DEC134-1EEF-41CF-99E2-781DB76BED83Q24235164-4CCF1015-D50F-4E01-837F-DBE5D7F5C9F8Q24240097-A3ABCBD6-1069-4AC0-ADD6-497113752EAAQ24244898-92406D56-42D7-4342-B4E5-DF47E19DDCACQ24644585-EB1E2939-89B2-4A04-B805-FDEA98F3E437Q24656164-64A33122-A57A-4CD8-92A8-A871820EDF1DQ26739661-0AAAE3C7-76C8-4264-84C3-FA90596BF5D3Q26783333-CDD94A81-65CA-4EE7-9A8C-4F0E97EE972FQ26825261-798C7229-4DD8-4C9B-B9E2-88B8B05CE49FQ26852219-B13C05A1-2547-4187-81D1-F8768862E986Q27008731-18585686-9897-4E04-B3C1-9478C3AC1F16Q27314988-53EE9079-E353-4BBE-B496-8A60F2E8EBD1Q28389402-75EBA7ED-39E8-40A9-A0B7-7CA0980F01B0Q28473860-350AE423-995A-453E-AD5C-E6CCA8D0C8FEQ28486193-91D0DC08-5175-44B9-AC6A-050D30B45FD2Q28545064-39B8CB26-442F-426A-ACE8-80856BA845A8Q30227214-975384DE-F3CB-453E-B41A-0D27A9FF14D9Q30227297-A3F27501-27A9-4405-BECF-BC10D435511EQ30229485-2A07B33F-E24F-4222-B3DD-F3B6EE186CEDQ30233084-B9BB2E8C-3470-489C-980A-EB133DA48704Q30235281-F75A5E3C-85CA-4050-8E88-A4155B7857ABQ30350565-12D02210-0B2C-4BF5-9321-B16AC6BD62BEQ30351240-8A430B5D-692F-4D25-A542-0F19345774D5Q30351736-35175645-370B-4836-BED4-A1F70890CB7FQ30352052-9EA27708-7DA0-4D64-ACA8-F75432E9C904Q30353079-CE93E420-E3E0-4576-A38B-5A192AEB24ADQ30353151-B1639331-4A02-4F88-AA9C-1E4638E34C95Q30355570-459E26FD-0921-4962-80B9-93A457F5A278Q30356962-078A003D-4824-4C68-8EB5-0B395FD8AA4EQ30358735-0E1CE9BF-C2F2-46D5-894A-3A5129279E94Q30359034-142E9956-1A7A-401A-AFA8-7D768AA6D5CCQ30362161-F605133F-0370-4641-86AE-FFC5DAEB76F7Q30364977-1C55617A-850D-4588-85D4-C249823CFF6CQ30365466-6DB44E60-65A8-4A03-AEAC-FF00CA8B845AQ30366153-4980157A-55E6-49AB-B050-BC8050822A6CQ30367643-BB2348DF-C638-4711-B3A4-11869491A169
P2860
Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Impact of oseltamivir treatmen ...... ications and hospitalizations.
@ast
Impact of oseltamivir treatmen ...... ications and hospitalizations.
@en
Impact of oseltamivir treatmen ...... ications and hospitalizations.
@nl
type
label
Impact of oseltamivir treatmen ...... ications and hospitalizations.
@ast
Impact of oseltamivir treatmen ...... ications and hospitalizations.
@en
Impact of oseltamivir treatmen ...... ications and hospitalizations.
@nl
prefLabel
Impact of oseltamivir treatmen ...... ications and hospitalizations.
@ast
Impact of oseltamivir treatmen ...... ications and hospitalizations.
@en
Impact of oseltamivir treatmen ...... ications and hospitalizations.
@nl
P2093
P1476
Impact of oseltamivir treatmen ...... lications and hospitalizations
@en
P2093
Cynthia Wat
Laurent Kaiser
Paul Mahoney
Tracy Mills
P304
P356
10.1001/ARCHINTE.163.14.1667
P407
P577
2003-07-01T00:00:00Z